MSET — Mindset pharma Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- CA$74.96m
- CA$67.85m
- CA$3.91m
Annual balance sheet for Mindset pharma, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Cash and Short Term Investments | 0.541 | 6.58 | 8.71 |
| Net Total Receivables | 0.021 | 0.517 | 0.47 |
| Prepaid Expenses | |||
| Total Current Assets | 0.561 | 9.88 | 9.61 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 0 | 0.2 | 0.156 |
| Total Assets | 0.561 | 10.1 | 9.77 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.092 | 0.893 | 8.15 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.092 | 1.06 | 8.28 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 0.469 | 9.02 | 1.49 |
| Total Liabilities & Shareholders' Equity | 0.561 | 10.1 | 9.77 |
| Total Common Shares Outstanding |